Related Experiment Videos
Constant morphine infusion for severe sickle cell crisis pain
Abstract:
The use of a constant infusion of intravenous morphine sulfate in a patient with severe sickle cell crisis is described. After several days of poor control with intramuscular and intravenous narcotic injections, adequate analgesia was obtained with the infusion of morphine within two hours of initiation of therapy. No adverse effects were noted. With the advantages provided by an intravenous narcotic infusion, this protocol should be considered as a suitable alternative to conventional methods for providing pain control in patients in sickle cell crisis.
Insights
Continuous intravenous morphine infusion effectively managed severe sickle cell crisis pain. This method provided rapid, safe analgesia when intermittent injections failed, offering a superior alternative for pain control.
Area of Science:
- Pain Management
- Hematology
- Pharmacology
Background:
- Severe sickle cell crisis often presents with intractable pain.
- Conventional intermittent narcotic injections may provide inadequate analgesia.
Observation:
- A patient with severe sickle cell crisis experienced poor pain control with standard intermittent opioid therapy.
- Continuous intravenous infusion of morphine sulfate was initiated.
Findings:
- Adequate pain relief was achieved within two hours of starting the morphine infusion.
- No adverse effects were observed during the continuous infusion therapy.
Implications:
- Continuous intravenous narcotic infusion offers an effective and safe alternative for managing sickle cell crisis pain.
- This protocol may improve patient outcomes compared to intermittent injection methods.